Table 1 Baseline of study subjects
Variables | Well controlled group (n = 151) | Uncontrolled group (n = 80) | p-value |
|---|---|---|---|
Age, years, mean ± SD | 43.20 ± 14.68 | 48.50 ± 14.22 | 0.009 |
Gender (N, %) | 0.483 | ||
Male | 65 (43.0) | 30 (37.5) | |
Female | 86 (57.0) | 50 (62.5) | |
Duration of regular ICS treatment, years, mean ± SD | 3.66 ± 4.42 | 5.14 ± 5.22 | 0.039 |
Age of asthma onset (N, %) | 0.524 | ||
< 18-year old | 39 (25.8) | 18 (22.5) | |
18–45 years of age | 82 (54.3) | 41(51.2) | |
> 45-year old | 30 (19.9) | 21(26.3) | |
Duration of asthma (N, %) | 0.002 | ||
< 5 years | 86 (57.0) | 27 (33.8) | |
5–10 years | 24 (15.8) | 14 (17.5) | |
> 10 years | 41 (27.2)a | 39 (48.7)a | |
Education level (N, %) | 0.072 | ||
Primary education | 6 (4.0) | 5 (6.3) | |
Secondary education | 14 (9.3) | 16 (20.0) | |
Senior high education | 20 (13.2) | 12 (15.0) | |
University education | 111 (73.5) | 47 (58.8) | |
Occupation (N, %) | 0.043 | ||
Physical labor | 7 (4.6) | 6 (7.5) | |
Office work | 84 (55.6) | 39 (48.8) | |
Participants unemployed | 50 (33.1) | 35 (43.8) | |
Student | 10 (6.6) | 0 (0) | |
Current maintenance treatment | 0.752 | ||
ICS | 8 (5.3) | 3 (3.8) | |
ICS + LABA | 143 (94.7) | 77 (96.3) | |
MARS-A score, mean ± SD | 4.32 ± 0.91 | 3.83 ± 1.22 | 0.006 |
FEV1% predicted, mean ± SD | 84.13 ± 23.82 | 72.89 ± 25.10 | 0.014 |
FENO ppb, mean ± SD | 48.28 ± 37.46 | 49.19 ± 28.17 | 0.357 |
ACT score | 23.11 ± 1.54 | 15.45 ± 3.20 | 0.000 |